Biểu đồ giá cổ phiếu SER
SER Thu nhập
Serina Therapeutics Inc
$2.35
5.38%
$0.12
Khi đóng cửa: Aug 06, 16:00:00 GMT-4
$2.26
-3.82%
$-0.09
Phiên trước giờ: Aug 07, 07:30:07 GMT-4
Quay lại
Serina Therapeutics Inc (SER) Thu nhập
Thống kê chính
Giá đóng cửa trước
$2.23
Giá mở cửa
$2.14
Phạm vi ngày
$2.14 - $2.39
Phạm vi 52 tuần
$1.22 - $7.92
Khối lượng
69.7K
Khối lượng trung bình
115.0K
Tỷ suất cổ tức
--
EPS (TTM)
-1.89
Vốn hóa thị trường
$33.9M
SER là gì?
Serina Therapeutics, Inc. operates as a clinical-stage biotechnology company, which engages in the research and development of polymer technology. The company is headquartered in Huntsville, Alabama and currently employs 16 full-time employees. The company went IPO on 2018-11-29. The firm's POZ Platform provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs). Its proprietary POZ technology is based on a synthetic, water soluble, low viscosity polymer called poly(2-oxazoline). Its POZ technology is engineered to provide greater control in drug loading and more precision in the rate of release of attached drugs delivered via subcutaneous injection. SER-252 is the Company’s lead candidate for advanced Parkinson’s disease. SER-252 is an investigational apomorphine therapy developed with its POZ platform and designed to provide continuous dopaminergic stimulation.
